Recombinant Anti-dabigatran MAb Fab

Cat

MOM-H40-F(P)

Product Overview

Recombinant Humanized Antibody Fab Fragment specifically binds to dabigatran, expressed in E. coli

Target

dabigatran

Type

Humanized Fab - G1 - kappa

Species Reactivity

N/A

Expression Host

E. coli

Applications

Suitable for use in FC, IP, ELISA, Neut, FuncS, IF and most other immunological methods.

Specificity

dabigatran etexilate mesylate (Pradaxa)

Purity

>95.0% as determined by analysis by SDS-PAGE.

Purification

Purified by Nickel ion affinity chromatography

Storage

Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freeze/thaw cycles.

Introduction

Dabigatran (Pradaxa in Australia, Canada, Europe and USA, Prazaxa in Japan) is an oral anticoagulant from the class of the direct thrombin inhibitors. It is being studied for various clinical indications and in some cases it offers an alternative to warfarin as the preferred orally administered anticoagulant ("blood thinner") since it does not require blood tests for international normalized ratio (INR) monitoring while offering similar results in terms of efficacy

Keywords

dabigatran; Pradaxa; Pradax; Prazaxa

Download Datasheet:

MOM-18498-F(E)

Recombinant Anti-Human tmeff2 Antibody Fab Fragment

MOM-18539-F(E)

Recombinant Anti-Human cd5 Antibody Fab Fragment

MOM-18013-F(E)

Recombinant Anti-Human CD33 Antibody Fab Fragment

MOM-18547-F(P)

Recombinant Anti-Human cxcl10 Antibody Fab Fragment

MOM-18550-F(E)

Recombinant Anti-Human dkk1 Antibody Fab Fragment

MOM-18140-F(E)

Recombinant Anti-Human TGFB1 Antibody Fab Fragment

MOM-18451-F(P)

Recombinant Anti-Human notum Antibody Fab Fragment

MOM-18279-F(E)

Recombinant Anti-Human tnfsf13 Antibody Fab Fragment

MOM-18044-F(P)

Recombinant Anti-Human ITGB2 Antibody Fab Fragment

MOM-18549-F(P)

Recombinant Anti-Human cxcr4 Antibody Fab Fragment